Matt Lechner

ORCID: 0000-0002-7123-0773
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Surgical Oncology
  • Olfactory and Sensory Function Studies
  • Head and Neck Cancer Studies
  • Sinusitis and nasal conditions
  • Cervical Cancer and HPV Research
  • Advanced Chemical Sensor Technologies
  • Long-Term Effects of COVID-19
  • Obstructive Sleep Apnea Research
  • Nasal Surgery and Airway Studies
  • Ear and Head Tumors
  • Oral and Maxillofacial Pathology
  • Salivary Gland Tumors Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Allergic Rhinitis and Sensitization
  • Epigenetics and DNA Methylation
  • Esophageal Cancer Research and Treatment
  • Neuroscience of respiration and sleep
  • Cancer-related molecular mechanisms research
  • Vestibular and auditory disorders
  • Cancer Immunotherapy and Biomarkers
  • Hearing, Cochlea, Tinnitus, Genetics
  • Tracheal and airway disorders
  • Glaucoma and retinal disorders
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies

CRUK Lung Cancer Centre of Excellence
2016-2025

University College London
2016-2025

University of East Anglia
2024

University College London Hospitals NHS Foundation Trust
2013-2024

National Hospital for Neurology and Neurosurgery
2024

Cancer Institute (WIA)
2016-2024

Barts Health NHS Trust
2019-2023

Homerton University Hospital NHS Foundation Trust
2023

Stanford University
2020-2023

Royal London Hospital
2016-2022

David Capper David Jones Martin Sill Volker Hovestadt Daniel Schrimpf and 95 more Dominik Sturm Christian Koelsche Felix Sahm Lukas Chávez David Reuß Annekathrin Kratz Annika K. Wefers Kristin Huang Kristian W. Pajtler Leonille Schweizer Damian Stichel Adriana Olar Nils W. Engel Kerstin Lindenberg Patrick N. Harter Anne K. Braczynski Karl H. Plate Hildegard Dohmen Boyan K. Garvalov Roland Coras Annett Hölsken Ekkehard Hewer Melanie Bewerunge‐Hudler Matthias Schick Roger Fischer Rudi Beschorner Jens Schittenhelm Ori Staszewski Khalida Wani Pascale Varlet Mélanie Pagès Petra Temming Dietmar Lohmann Florian Selt Hendrik Witt Till Milde Olaf Witt Eleonora Aronica Felice Giangaspero Elisabeth J. Rushing Wolfram Scheurlen Christoph Geisenberger Fausto J. Rodríguez Albert J. Becker Matthias Preusser Christine Haberler Rolf Bjerkvig Jane Cryan Michael A. Farrell Martina Deckert Jürgen Hench Stephan Frank Jonathan Serrano Kasthuri Kannan Aristotelis Tsirigos Wolfgang Brück Silvia Höfer Stefanie Brehmer Marcel Seiz‐Rosenhagen Daniel Hänggi Volkmar Hans Stephanie Rozsnoki Jordan R. Hansford Patricia Kohlhof Bjarne Winther Kristensen Matt Lechner Beatriz Lopes Christian Mawrin Ralf Ketter Andreas E. Kulozik Ziad Khatib Frank L. Heppner Arend Koch Anne Jouvet Catherine Keohane Helmut Mühleisen Wolf Mueller Ute Pohl Marco Prinz Axel Benner Marc Zapatka Nicholas G. Gottardo Pablo Hernáiz Driever Christof M. Kramm Hermann L. Müller Stefan Rutkowski Katja von Hoff Michael C. Frühwald Astrid Gnekow Gudrun Fleischhack Stephan Tippelt Gabriele Calaminus Camelia‐Maria Monoranu Arie Perry Chris Jones

10.1038/nature26000 article EN Nature 2018-03-13

Abstract Gains and losses of DNA are prevalent in cancer emerge as a consequence inter-related processes replication stress, mitotic errors, spindle multipolarity breakage–fusion–bridge cycles, among others, which may lead to chromosomal instability aneuploidy 1,2 . These copy number alterations contribute initiation, progression therapeutic resistance 3–5 Here we present conceptual framework examine the patterns human that is widely applicable diverse data types, including whole-genome...

10.1038/s41586-022-04738-6 article EN cc-by Nature 2022-06-15

Abstract The nature and extent of immune cell infiltration into solid tumours are key determinants therapeutic response. Here, using a DNA methylation-based approach to tumour fraction deconvolution, we report the integrated analysis composition genomics across wide spectrum cancers. Initially studying head neck squamous carcinoma, identify two distinct subgroups: ‘immune hot’ cold’, which display differing prognosis, mutation burden, cytokine signalling, cytolytic activity oncogenic driver...

10.1038/s41467-018-05570-1 article EN cc-by Nature Communications 2018-08-07

Bulk-tissue DNA methylomes represent an average over many different cell types, hampering our understanding of cell-type-specific contributions to disease development. As single-cell methylomics is not scalable large cohorts individuals, cost-effective computational solutions are needed, yet current methods limited tissues such as blood. Here we leverage the high-resolution nature tissue-specific RNA-sequencing datasets construct a methylation atlas defined for 13 solid tissue types and 40...

10.1038/s41592-022-01412-7 article EN cc-by Nature Methods 2022-03-01

Background: Since publication of the original Position Paper on Olfactory Dysfunction in 2017 (PPOD-17), personal and so- cietal burden olfactory disorders has come sharply into focus through lens COVID-19 pandemic. Clinicians, scientists public are now more aware importance olfaction, impact its dysfunction quality life, nutrition, social relationships mental health. Accordingly, new basic, translational clinical research resulted significant pro- gress since PPOD-17. In this updated...

10.4193/rhin22.483 article EN Rhinology Journal 2023-10-01

The diagnosis of sinonasal tumors is challenging due to a heterogeneous spectrum various differential diagnoses as well poorly defined, disputed entities such undifferentiated carcinomas (SNUCs). In this study, we apply machine learning algorithm based on DNA methylation patterns classify with clinical-grade reliability. We further show that SNUC morphology are not their current terminology suggests but rather reassigned four distinct molecular classes defined by epigenetic, mutational and...

10.1038/s41467-022-34815-3 article EN cc-by Nature Communications 2022-11-28

Abstract Nasopharyngeal cancer (NPC), endemic in Southeast Asia, lacks effective diagnostic and therapeutic strategies. Even high-income countries the 5-year survival rate for stage IV NPC is less than 40%. Here we report high somatostatin receptor 2 (SSTR2) expression multiple clinical cohorts comprising 402 primary, locally recurrent metastatic NPCs. We show that SSTR2 induced by Epstein–Barr virus (EBV) latent membrane protein 1 (LMP1) via NF-κB pathway. Using cell-based preclinical...

10.1038/s41467-020-20308-8 article EN cc-by Nature Communications 2021-01-05

Abstract Background Loss of smell and/or taste are cardinal symptoms COVID-19. ‘Long-COVID’, persistence symptoms, affects around one fifth people. However, data regarding the clinical resolution loss lacking. In this study we assess and at 4–6 week follow-up, aim to identify risk factors for persistent describe as a feature long-COVID in community cohort London with known SARS-CoV-2 IgG/IgM antibody status. We also compare subjective objective assessments subset participants. Methods Four...

10.1186/s12879-021-05927-w article EN cc-by BMC Infectious Diseases 2021-02-25

Human papillomavirus (HPV)-associated cervical cancer is a leading cause of deaths in women. Here we present an integrated multi-omic analysis 643 squamous cell carcinomas (CSCC, the most common histological variant cancer), representing patient populations from USA, Europe and Sub-Saharan Africa identify two CSCC subtypes (C1 C2) with differing prognosis. C1 C2 tumours can be driven by either HPV types (16 18) while HPV16 HPV18 are overrepresented among respectively, prognostic difference...

10.1038/s41467-022-33544-x article EN cc-by Nature Communications 2022-10-07

Objectives It has been demonstrated that reduction in smell and/or taste is the most predictive symptom SARS-CoV-2/Covid-19 infection. We used Google Trends to analyze regional searches relating loss of and across Italy, Spain, France, Brazil, United States America determined association with reported Covid-19 cases.

10.1080/14787210.2020.1792289 article EN Expert Review of Anti-infective Therapy 2020-07-16
Matt Lechner Yoko Takahashi Mario Turri‐Zanoni Jacklyn Liu Nicholas Counsell and 95 more Mario Hermsen Raman Preet Kaur Tianna Zhao Murugappan Ramanathan Volker Hans Schartinger Oscar Emanuel Sam Helman Jordan Varghese József Dudás Herbert Riechelmann Susanne Sprung Johannes Haybaeck David Howard Nils W. Engel Sarah Stewart Laura Brooks Jessica C. Pickles Thomas S. Jacques Tim R. Fenton Luke Williams Francis Vaz Paul O’Flynn Paul Stimpson Shih‐Yu Wang S. Alam Hannan Samit Unadkat Jonathan Hughes Raghav C. Dwivedi Cillian T. Forde Premjit S. Randhawa Simon Gane J. Joseph Peter Andrews Gary Royle Alessandro Franchi Roberta Maragliano Simonetta Battocchio Helen Bewicke‐Copley Christodoulos P. Pipinikas Amy P. Webster Chrissie Thirlwell Debbie L. L. Ho Andrew E. Teschendorff Tianyu Zhu Christopher D. Steele Nischalan Pillay Bart Vanhaesebroeck Ahmed Mohyeldin Juan C. Fernandez‐Miranda Ki Wan Park Quynh‐Thu Le Robert B. West Rami Saade R. Peter Manes Sacit Bulent Omay Eugenia M. Vining Benjamin L. Judson Wendell G. Yarbrough Maddalena Sansovini Silvia Nicolini Ilaria Grassi Alberto Bongiovanni David Capper Ulrich Schüller Selvam Thavaraj Ann Sandison Pavol Šurda Claire Hopkins Marco Ferrari Davide Mattavelli Vittorio Rampinelli Fabio Facchetti Piero Nicolai Paolo Bossi Oswaldo A. Henriquez Kelly R. Magliocca C. Arturo Solares Sarah K. Wise José Luís Llorente Zara M. Patel Jayakar V. Nayak Peter H. Hwang Peter D. Lacy Robbie Woods James P. O’Neill Amrita Jay Dawn Carnell Martin Förster Masaru Ishii Nyall R. London Diana Bell Gary L. Gallia Paolo Castelnuovo Stefano Severi Valerie J. Lund

10.1016/j.ejca.2021.09.046 article EN European Journal of Cancer 2021-12-31

Abstract Objectives Sinonasal mucosal melanoma (SNMM) is an extremely rare and challenging sinonasal malignancy with a poor prognosis. Standard treatment involves complete surgical resection, but the role of adjuvant therapy remains unclear. Crucially, our understanding its clinical presentation, course, optimal limited, few advancements in improving management have been made recent past. Methods We conducted international multicenter retrospective analysis 505 SNMM cases from 11...

10.1055/s-0042-1750178 article EN Journal of Neurological Surgery Part B Skull Base 2022-07-10

Background: Olfactory dysfunction is a cardinal symptom of COVID-19 infection, however, studies assessing long-term olfactory are limited and no randomised-controlled trials (RCTs) early training have been conducted. Methodology: We conducted prospective, multi-centre study consisting baseline psychophysical measurements smell taste function. Eligible participants were further recruited into 12-week RCT versus control (safety information). Patient-reported outcomes measured using an...

10.4193/rhin21.470 article EN Rhinology Journal 2022-06-01
Coming Soon ...